Adage Capital Partners Gp, L.L.C. Fulcrum Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,000,000 shares of FULC stock, worth $10.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,000,000
Previous 2,000,000
50.0%
Holding current value
$10.8 Million
Previous $7.14 Million
97.48%
% of portfolio
0.03%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding FULC
# of Institutions
130Shares Held
51.6MCall Options Held
1.04MPut Options Held
32.6K-
Ra Capital Management, L.P. Boston, MA10.2MShares$36.7 Million0.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$18.8 Million4.03% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$17.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$17.2 Million1.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.34MShares$12 Million0.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $187M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...